Traws Pharma, Inc. (NASDAQ: TRAW) shared encouraging findings on its investigational antiviral drug, tivoxavir marboxil (TXM) ...

In this episode of Lexicon, Dr. Nazlie Latefi shares the fascinating science behind BioVanta, the challenges of bringing a ...

Existing flu antivirals may not work well against H5N1; avoiding raw milk and reducing dairy worker exposure may be the best ...

COVID and the 1918 flu pandemic gave us playbooks on how to prepare for the next pandemic. But we aren’t using it.

Poster underscores Tivoxavir Marboxil’s potential for the treatment of bird flu, supported by 100% survival in a rodent challenge model, potent ...

This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.

UVA School of Medicine emeritus professor Dr. Frederick G. Hayden helped design the trial and presented the results Wednesday ...

A total of 9% of placebo recipients contracted COVID-19 from a household member, compared with 3% of ensitrelvir recipients, ...

The share of flu tests coming back positive at the beginning of March was still higher than at the same time last year, ...

The findings come at a time when outbreaks of bird flu -- a different subtype of the ... Study Shows Drop in Use of Antiviral Medications in Young Children With Influenza Dec. 17, 2024 — Despite ...

In a new study, results suggest that in a preclinical model, two FDA-approved flu antivirals did not successfully treat ...

The recent live bird market cases represent the second and third known cases of avian influenza in Philadelphia. In January, ...